Texas Children’s Hospital joins bioMérieux GNAS CoE

Texas Children’s Hospital is the newest facility inducted into the bioMérieux global Antimicrobial Stewardship Center of Excellence program. bioMérieux, is proud to partner with Texas Children’s. The partnership symbolizes a collective commitment to continued excellence in managing AMR by advancing antimicrobial stewardship (AMS) with cutting-edge solutions.

Texas Children’s and bioMérieux will work together to further activate specific AMS initiatives that will improve patient care, while leveraging shared expertise to develop and scale innovative best practices based on the application of game-changing diagnostic technology. The collaboration aims to curb the dangers associated with AMR, such as the transmission of multi-drug resistant organisms (MDROs).

“This is not merely a recognition – it symbolizes a profound partnership with Texas Children’s,” said Jennifer Zinn, Executive Vice President, Clinical Operations, bioMérieux. “We are committed to empowering robust stewardship interventions and capturing real-world evidence of their effects on patient outcomes and healthcare costs. In collaboration with Texas Children’s, we aim to emphasize industry best practices in diagnostic stewardship. Leveraging our clinical diagnostic portfolio, medical education, lab consultancy services, and information technology solutions, we aspire to fortify AMS initiatives even further.”

AMR is a major concern for pediatricians globally. Because children have weaker immune systems, this particular group is more vulnerable to infections and diseases. To combat AMR among younger populations, a holistic focus on AMS in pediatrics is essential.

“By collaborating with bioMérieux, we can deliver diagnostic-driven insights that directly impact patient therapy and accelerate our stewardship program impact,” said Dr. James Versalovic, Pathologist-in-Chief at Texas Children’s Hospital and Director of Texas Children’s Microbiome Center and a Milton J. Finegold Professor and Vice Chair, Pathology & Immunology, Baylor College of Medicine. “Our teams work diligently to engage all Texas Children’s stakeholders in our AMS initiatives. We want to set the best possible example for other health systems that might be figuring out how to get started or overcome barriers. Together, we can all make a difference in the fight against AMR.”

Texas Children’s is now one of three health systems in North America to join bioMérieux’s global Antimicrobial Stewardship Center of Excellence initiative. Texas Children’s has consistently been ranked as the No. 1 children’s hospital in Texas and placed third nationally in the U.S. News & World Report 2023-2024 Best Children’s Hospitals report.
MB Bureau